SIGN-UP

Participate in Research

Our team of professionals are trained to conduct clinical trials for people who want to quit smoking.

Our trials test medications, behavioral approaches and various combinations of both in an attempt to find the most effective smoking cessation treatment. Our staff is also trained to conduct behavioral counseling.

The BuZonE RCT Study

The main purpose of this research study is to see if taking a combination of zonisamide and bupropion for a short time helps you switch to using only an e-cigarette. Zonisamide is a drug approved by the United States Food and Drug Administration (FDA) for treatment of seizures. Bupropion (also known as Zyban) is a drug approved by the FDA for use as an aid to quit smoking (but not for switching from combustible cigarettes to e-cigarettes). The use of the combination of zonisamide and bupropion is not FDA approved for the purpose of switching from combustible cigarettes to e-cigarette use and is therefore considered investigational for this study.

BuZonE RCT FAQ

1What are the criteria to participate?

Between 21-65 years old
Desire to switch to an e-cigarette
Willingness to take study medications as directed
Currently smoke 10 or more cigarettes per day
Able to pass a urine drug test
No current serious medical conditions
No use of other tobacco products in the last 14 days

2How long is the study?

Your participation in this study will last about 13-14 weeks and will include seven visits to the study center. The initial on-site Screening Visit (Study Visit 1) will last about 2 to 2 ½ hours. All other study visits will last about 1 hour.

3Will I be compensated for my participation in this study?

You will be compensated for your time and inconvenience related to your participation in this study. If you do not complete the study, for any reason, you will be paid for the study visits and tasks you do complete according to the following schedule:

You will receive $25 for completing all of the on-site screening tests at Study Visit 1. In order to combat rising gas prices, you will receive an additional $25 for completing the initial screening visit ($50 total).

You will receive $75 for each completed visit; Study Visit 2 through Study Visit 7 ($450 total).

You will receive $5 a day for responding to daily surveys through eResearch. In order to receive compensation, you will need to answer all of the questions before you receive your next survey. Daily surveys will be sent once per day for approximately 89 days ($445 total).

If you return to the office for a 6-month CO reading you will receive an additional $75.

4Who is funding the study?

The study is being funded by a grant from the Foundation for a Smoke-Free World. The study investigator and research staff are being paid to conduct this study. The Foundation for a Smoke-Free World is an independent non-profit organization that receives funding from Philip Morris International (a company which manufactures cigarettes).

JUMP FAQ

1What are the criteria to participate?

Between 22-29 years old
Willing to try menthol flavored e-cigarettes
Currently smokes commercially available combustible cigarettes per day
No known allergies or sensitivities to any ingredients found in tobacco or e-cigarette products or any of the components in e-liquids (nicotine, flavor, benzoic acid, propylene glycol and glycerol, menthol, peppermint oil)
No current serious medical conditions
Able to read, understand, and willing to sign an informed consent form (ICF) and complete questionnaires written in English
Not pregnant, breastfeeding, or planning to become pregnant

2How long is the study?

Your participation in this study will last two to three weeks and will include six visits to the study center. The Screening Session (Visit 1), including the first product use will last approximately 1-2 hours. The other five study sessions will last approximately 30-45 minutes.

3Will I be compensated for my participation in this study?

You will be compensated for your time and inconvenience related to your participation in this study. If you do not complete the study, for any reason, you will be paid for the study visits you do complete according to the following schedule: The maximum compensation you may receive without unscheduled visits is $825

Participants will receive $25 for completing screening procedures at Study Visit 1. After all screening procedures, if participants are eligible to continue in the study, they will try the first product and will receive an additional $75. Participants will also receive $25 at this visit to cover the cost of gas price increases.
Following completion of each product-use session (Visit 2 through Visit 6) participants will receive $75 and an additional payment of $25 to cover the cost of gas price increases ($100 total per visit).
Participants who complete all product-use sessions will be eligible for a one-time payment of $200 that will be paid at the completion of all procedures at Visit 6.

If participants are asked by study staff to return to the center to complete or redo parts of a visit due to equipment malfunctions or other circumstances that are beyond their control, they may be reimbursed for mileage.

4Who is funding the study?

The study is being funded by Juul Labs, Inc.

The JUMP Study

The purpose of this research study is to have you try and rate the current and new menthol flavors of one brand, two other menthol-flavored e-cigarettes, and your usual brand of combustible cigarettes. You will use one of each of these products for 20 minutes (one at each study visit). After the 20-minute product-use time, you will complete questionnaires based on the experience.

The BIDI Study

The main purpose of this study is to evaluate how much you reduce smoking when using the BIDI e-cigarette. We will also provide additional instructions for you to use the device prior to smoking to determine if this helps with complete switching.

BIDI FAQ

1What are the criteria to participate?

Able to read, understand, and willing to sign an informed consent form (ICF) and complete questionnaires written in English
Between 22-65 years old
Able to pass a urine drug screen
Interested in switiching to an e-cigarette
Owns a smartphone with text message and data capabilities
Currently smoke 10 or more cigarettes per day
Not pregnant, nursing, or planning to become pregnant
No current serious medical conditions
No use of other tobacco products in the last 14 days

2How long is the study?

Your participation in this study will last about 12 weeks and will include seven visits to the study center. The initial on-site Screening Visit (Study Visit 1) will last approximately 2 hours. All other study visits will last approximately 1 hour.

3Will I be compensated for my participation in this study?

You will be compensated up to $1,145 for your time and inconvenience related to your participation in this study. If you do not complete the study, for any reason, you will be paid for the study visits and tasks you do complete according to the following schedule:

You will receive $50 for completing all of the on-site screening tests at Study Visit 1. ($50 total).

You will receive $100 for each completed visit; Study Visit 2 through Study Visit 7 ($600 total).

If you return to the office for a 6-month CO reading you will receive an additional $75.

4Who is funding the study?

The study is being funded by a grant from the Foundation for a Smoke-Free World.

SIGN-UP

For Future Studies

Fill out our form below for more information

Participant information is maintained in a volunteer database system and retained for future studies as they become available. Pertinent information is confidentially kept on file to aid in selecting highly qualified candidates for research studies.

Why should I participate?

Participants may gain access to new research treatments before they are widely available.

Additionally, participants are compensated for their time and receive study-related products and medications at no cost. You may be among the first to benefit if the approach being studied is found to be helpful.

PARTICIPATE IN A CLINICAL STUDY